Goserelin
Zoladex LA: A Subcutaneous Implant, White to Off-White in Color, Cylindrical in Shape, Containing 10.8 mg of Goserelin.
Goserelin, the Active Substance of Zoladex LA, Is a Synthetic Equivalent of the Naturally Occurring Hormone - Gonadorelin (LHRH - Luteinizing Hormone-Releasing Hormone).
It Belongs to a Group of Medicines Called Gonadorelin Analogues. The Prolonged Action of Goserelin Leads to a Decrease in Testosterone Levels (Male Sex Hormone) in Men. This Effect Is Reversible After Treatment Is Stopped.
Zoladex LA Is Used to Treat Prostate Cancer That Responds to Hormonal Treatment.
Tell Your Doctor If You Have Ever Had Any Problems Before When Using a Medicine Containing Goserelin, Any of the Ingredients Listed in Section 6, or Any Other Medicine in the Same Group as Zoladex LA (LHRH Analogues).
Also, Tell Your Doctor If You Have Ever Had Any Problems with Other Medicines.
Before Starting Treatment, Tell Your Doctor About All Your Health Problems, Especially Bone Diseases and Pain, Urination Problems, Diabetes, Depression, and High Blood Pressure.
Tell Your Doctor If You Have Ever Had Any Heart or Blood Vessel Problems, Including Heart Rhythm Problems (Arrhythmia), or If You Are Taking Medicines for These Problems. The Risk of Heart Rhythm Problems May Be Increased When Using Zoladex LA.
Consult Your Doctor Even If the Above Warnings Apply to Past Situations.
The Decision to Stop Treatment with Zoladex LA Should Be Made by the Doctor Who Prescribed It for You.
If You Are Admitted to Hospital, Tell the Medical Staff That You Are Using Zoladex LA.
Medicines in This Group Can Cause Loss of Bone Density and Decreased Glucose Tolerance.
Zoladex LA Should Not Be Used in Children.
Tell Your Doctor About All Medicines You Are Taking Now or Have Recently Taken, Including Those You Have Bought Without a Prescription and Herbal Medicines.
Zoladex LA May Affect the Action of Some Medicines Used to Treat Heart Rhythm Problems (Such as Quinidine, Procainamide, Amiodarone, and Sotalol) or May Increase the Risk of Heart Rhythm Problems When Used with Certain Other Medicines [Such as Methadone Used for Pain Relief and in Drug Detoxification, Moxifloxacin (an Antibiotic), and Antipsychotic Medicines Used to Treat Serious Mental Illnesses].
Not Applicable.
Zoladex LA Is Not Intended for Use in Women.
There Is No Data on the Effects of Zoladex LA on the Ability to Drive and Use Machines.
This Medicine Should Always Be Used Exactly as Your Doctor or Pharmacist Has Told You. If You Are Not Sure, Check with Your Doctor or Pharmacist.
One Implant, Containing 10.8 mg of Goserelin, Is Injected Under the Skin, into the Front Wall of the Abdomen, by a Doctor or Nurse, Every 12 Weeks.
If You Feel That the Effect of Zoladex LA Is Too Strong or Too Weak, Talk to Your Doctor.
Zoladex LA Is Given by a Doctor or Nurse in a Clinic or Hospital Setting. It Is Unlikely That You Will Be Given Too Much Goserelin. However, If You Are Given Too Much, Tell Your Doctor as Soon as Possible.
Zoladex LA Should Be Injected Regularly Every 12 Weeks. Always Make an Appointment with Your Doctor or Nurse for the Next Injection. Remember, the Interval Between Injections Should Not Be Too Long or Too Short. If the Interval Is Longer Than 12 Weeks, Tell Your Doctor as Soon as Possible.
Do Not Stop Using Zoladex LA Without Talking to Your Doctor. This Includes If You Feel Better.
Like All Medicines, This Medicine Can Cause Side Effects, Although Not Everybody Gets Them.
The Following Side Effects May Happen with Zoladex LA:
The List of Side Effects Is Not Exhaustive. You Might Not Experience Any of Them.
If You Experience Any Side Effects, Including Those Not Listed in This Leaflet, Tell Your Doctor, Pharmacist, or Nurse. You Can Also Report Side Effects Directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Jerozolimskie Avenue 181C,
02-222 Warsaw,
Phone: +48 22 49 21 301,
Fax: +48 22 49 21 309,
Website: https://smz.ezdrowie.gov.pl.
You Can Also Report Side Effects to the Marketing Authorization Holder.
Reporting Side Effects Will Help to Gather More Information on the Safety of This Medicine.
Keep This Medicine Out of the Sight and Reach of Children.
Do Not Use This Medicine After the Expiry Date Which Is Stated on the Packaging. The Expiry Date Refers to the Last Day of the Month.
Store in a Temperature Not Exceeding 25°C.
Medicines Should Not Be Disposed of via Wastewater or Household Waste. Ask Your Pharmacist How to Dispose of Medicines No Longer Required. These Measures Will Help to Protect the Environment.
A Sterile, Pre-Filled Syringe with an Automatically Triggered Safety Needle Guard (Safe System), in a Foil Pouch, in a Carton.
AstraZeneca AB,
SE-151 85 Södertälje,
Sweden.
AstraZeneca AB,
Gärtunavägen,
SE-152 57 Södertälje,
Sweden.
For Further Information, Contact Your Local Representative of the Marketing Authorization Holder:
AstraZeneca Pharma Poland Sp. z o.o.,
Postępu Street 14,
02-676 Warsaw,
Phone: +48 22 245 73 00,
Fax: +48 22 485 30 07.
Date of Last Revision of the Leaflet:January 2024.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.